2025 Scottsdale Headache Symposium

Accreditation Statement
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The American Headache Society® designates this Live activity for a maximum of 21.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Headache Society® designates this enduring material (recorded sessions) for a maximum of 35.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Recorded sessions will be available via Education On Demand beginning Tuesday, December 23, 2025 through Tuesday, June 23, 2026. Pre-courses will be available separately.

AAFP
The AAFP has reviewed 2025 Scottsdale Headache Symposium and deemed it acceptable for up to 21.00 Live AAFP Elective credit(s). Term of Approval is from 12/4/2025 to 12/7/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABPN
THE AMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY HAS REVIEWED THE 2025 SCOTTSDALE HEADACHE SYMPOSIUM AND HAS APPROVED THIS ACTIVITY AS PART OF A COMPREHENSIVE SELF-ASSESSMENT (SA) CME ACTIVITY, WHICH IS MANDATED BY THE ABMS AS A NECESSARY COMPONENT OF CONTINUING CERTIFICATION.

This activity awards up to 21.00  Category 1 CME which are approved as Self-Assessment credits. The approval period is for December 4-7, 2025.

Pharmacology
This content has been reviewed for pharmacology hours and the calculated value is: 16.25 hours of pharmacology content.